There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Most medical cost-effectiveness analyses include future costs only for related illnesses,
but this approach is controversial. This paper demonstrates that cost-effectiveness
analysis is consistent with lifetime utility maximization only if it includes all
future medical and non-medical expenditures. Estimates of the magnitude of these future
costs suggest that they may substantially alter both the absolute and relative cost-effectiveness
of medical interventions, particularly when an intervention increases length of life
more than quality of life. In older populations, current methods overstate the cost-effectiveness
of interventions which extend life compared to interventions which improve the quality
of life.